Right patient. Right diagnosis.Right treatment.
NeuroFirst™ Memory
A new blood test to assess memory complaints for people over 60
Right therapy.
Right patient.
Right time.
NeuroFirst™ Memory
A new earlier-detection blood test to assess memory complaints for people over 60
CxPM is an AI-driven diagnostics company. Our tests use a predictive algorithm and blood to rule out neurodegenerative disorders (Alzheimer’s Dementia and Parkinson’s Disease) in patients with possible early symptoms in primary care.
Cx Precision Medicine is Dedicated to Changing Expectations
The revolutionary NeuroFirstTM Memory test from Cx Precision Medicine is a simple blood test that can aid primary care physicians in assessing memory complaints for people 60 years old and up. The physician can differentiate between those patients who would benefit from further neurological testing and those whose symptoms are very unlikely to be caused by Alzheimer’s Dementia, resulting in peace of mind for the patient and more precise treatments.
Evidence Based Precision Medicine
A New Approach for Targeted Intervention
Our technology combines proteomics and artificial intelligence to drive the results of our tests. We measure a large number of proteins in blood then use our sophisticated algorithms, trained on thousands of samples, to drive the results.
Coming Soon
NeuroFirst™ Parkinson's test will help primary care physicians with the challenge of identifying patients who should be further evaluated for Parkinson's Disease
